| 1 |
35302484 | Oral Drugs Against COVID-19–Management of Drug Interactions With the Use of Nirmatrelvir/Ritonavir. | 2022 Apr 15 |
1 |
| 2 |
30951643 | Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment. | 2019 May |
2 |
| 3 |
26727525 | Chronic Effects of Ethanol and/or Darunavir/Ritonavir on U937 Monocytic Cells: Regulation of Cytochrome P450 and Antioxidant Enzymes, Oxidative Stress, and Cytotoxicity. | 2016 Jan |
1 |
| 4 |
26945713 | Cobicistat versus ritonavir boosting and differences in the drug-drug interaction profiles with co-medications. | 2016 Jul |
2 |
| 5 |
24973543 | Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivo. | 2014 Sep 1 |
2 |
| 6 |
23479398 | Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach. | 2013 Jul |
2 |
| 7 |
16162970 | In-vitro cytotoxicity of ET-743 (Trabectedin, Yondelis), a marine anti-cancer drug, in the Hep G2 cell line: influence of cytochrome P450 and phase II inhibition, and cytochrome P450 induction. | 2005 Oct |
1 |
| 8 |
16322314 | In vitro and in vivo clinical pharmacology of dimethyl benzoylphenylurea, a novel oral tubulin-interactive agent. | 2005 Dec 1 |
1 |
| 9 |
15247556 | Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction. | 2004 Aug 15 |
3 |
| 10 |
9533981 | Saquinavir. Clinical pharmacology and efficacy. | 1998 Mar |
1 |
| 11 |
9616191 | Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir. | 1998 Jun |
1 |
| 12 |
9056009 | Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir. | 1997 Mar |
3 |